Catalysis research could aid drug development

Products like pharmaceuticals have to be synthesized to have molecules of only one 'handedness' to match the structure of biomolecules in human proteins. Catalysts currently used to accomplish this are problematic. New research is helping to bring the goal of a solid 'chiral' catalyst that can easily be separated from its products closer to reality.